NCT06127550
taVNS for Letter Learning in Dyslexia
StatusEnrolling by Invitation
PhaseNot applicable
SponsorUniversity of Florida
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Trial status changed: Suspended → Enrolling by Invitation
- Eligibility criteria expanded, about 5 words
- Start date changed from estimate of Sep 1, 2026 to Nov 1, 2026
- Notable Start date: Aug 1, 2026 to Sep 1, 2026v7
- Stopped Trial status: Not Yet Recruiting to Suspended Sponsor's reason: Waiting on funding to support study
- Start date: Sep 1, 2025 to Aug 1, 2026
- Site contact updated
- Notable Start date: Jan 1, 2025 to Sep 1, 2025v5
- Notable Start date: Sep 1, 2024 to Jan 1, 2025v4
Show 2 earlier versionsHide 2 earlier versions
- Notable Start date: May 1, 2024 to Sep 1, 2024v3
- Notable Start date: Dec 1, 2023 to May 1, 2024
- Primary endpoints: 1 to 2
- Enrollment target: 120 to 100
- Secondary endpoints: 2 to 3
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Adverse events
Timeframe: 4 weeks
Compliance
Timeframe: 4 weeks
Secondary (3)
Letter ID
Decoding
Automaticity
Arms and interventions
Active taVNSExperimental
Participants will receive custom current at 5 Hz to the left auricular branch of the vagus nerve while learning new letter-sound relationships.
Sham taVNSSham comparator
Participants will undergo current thresholding but device will be turned off without their knowledge during the training.
Devices: active taVNS, sham taVNS
Sites
1 site in 1 country
- University of FloridaGainesville, Florida, United States